SYN1 and amyotrophic lateral sclerosis: In this study, we explored the possibility of using gene therapy to treat ALS by enhancing ADAR2 activity through delivery of the ADAR2 gene to mouse motor neurons using AAV9 as a vector, together with the SYNI promoter to achieve neuron-specific expression of the ADAR2 gene.